SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 161.17 |
| Enterprise Value ($M) | 155.50 |
| Book Value ($M) | 1.04 |
| Book Value / Share | 0.01 |
| Price / Book | 155.57 |
| NCAV ($M) | -23.81 |
| NCAV / Share | -0.14 |
| Price / NCAV | -6.77 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.17 |
| Return on Assets (ROA) | -1.04 |
| Return on Equity (ROE) | -2.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.71 |
| Current Ratio | 3.71 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 87.33 |
| Assets | 112.18 |
| Liabilities | 111.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -107.52 |
| Net Income | -101.17 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -96.51 |
| Cash from Investing | -14.88 |
| Cash from Financing | 88.52 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Acorn Bioventures, L.p. | 9.99 | ||
| 13G/A | Lincoln Park Capital Fund, LLC | 0.95 | -11.60 | |
| 13G/A | Orbimed Advisors Llc | 6.70 | 11.29 | |
| 13G/A | Bain Capital Life Sciences Fund, L.P. | 9.99 | 38.63 | |
| 13G/A | BlackRock Inc. | 4.90 | -3.05 | |
| 13G/A | Millennium Management Llc | 1.00 | -79.87 | |
| 13G/A | Empery Asset Management, LP | 2.65 | -26.60 | |
| 13D/A | Growth Equity Opportunities 18 VGE, LLC | 9.99 | 29.71 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 475,838 | 491,811 | 96.75 | |
| 327,582 | 388,217 | 84.38 | |
| 346,401 | 1,167,732 | 29.66 | |
| 386,083 | 1,850,405 | 20.86 | |
| 811,898 | 3,289,172 | 24.68 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| WINT – Windtree Therapeutics, Inc. | XBIO – Xenetic Biosciences, Inc. |
| XCUR – Exicure, Inc. | ZURA – Zura Bio Limited |
Financial data and stock pages provided by
Fintel.io